Clinical Trials Browser

HER2-positive Gastric Cancer × Tegafur × Gastrointestinal × Clear all

NCT06439550 2024-06-03

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

Phase 2 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer

NCT05070598 2021-10-07

Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer

Phase 2 Unknown

Gastrointestinal

HER2-positive Gastric Cancer